A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases

NCT01012323 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Immunodeficiency Diseases

Interventions

BIOLOGICAL: NewGam

Sponsor

Octapharma

Collaborators

[object Object]